JACOBS LEVY EQUITY MANAGEMENT, INC
Position in VIR — Vir Biotechnology, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,923,330
+$12,371,076 QoQ
Shares Held
1,442,336
+1391.3% QoQ
Ownership
0.855%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $706,432,200 across 86 Biotechnology names. VIR ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
214,160 | $165,468,582 | |
| 2 | INCY |
Incyte Corp
|
1,717,978 | $161,696,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
212,204 | $70,211,937 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
789,429 | $51,020,796 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,431,071 | $29,980,937 | |
| 6 | EXEL |
Exelixis, Inc.
|
425,982 | $18,270,367 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,097,189 | $16,260,340 | |
| 8 | ARVN |
Arvinas, Inc.
|
1,441,521 | $15,280,122 |
All Filings in VIR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,923,330 | 1,442,336 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $552,254 | 96,717 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $732,301 | 145,298 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $359,328 | 55,452 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $2,623,484 | 350,265 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,819,448 | 316,792 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,141,221 | 310,091 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,952,368 | 293,476 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,629,222 | 280,600 | Shares | Sole | 2023-11-17 | |
| 2022-09-30 | $369,578 | 19,169 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||